Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Toshner

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Circulation|July 27, 2012
Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertensionMark L Ormiston, Chiwen Chang, Lu L Long, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2023
Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertensionSathineni A Reddy, Emilia M Swietlik, Lucy Robertson, et al.
Nature Communications|December 31, 2025
Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitmentJingxu Guo, Karolina Kostrzyńska, Ioannis Kamzolas, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
The European Respiratory Journal|July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studiesS Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Thorax|March 31, 2022
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Circulation|July 27, 2012
Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertensionMark L Ormiston, Chiwen Chang, Lu L Long, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 18, 2023
Natural history of chronic thromboembolic pulmonary disease with no or mild pulmonary hypertensionSathineni A Reddy, Emilia M Swietlik, Lucy Robertson, et al.
Nature Communications|December 31, 2025
Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitmentJingxu Guo, Karolina Kostrzyńska, Ioannis Kamzolas, et al.
Circulation|November 25, 2016
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J Rhodes, Pavandeep Ghataorhe, John Wharton, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
The European Respiratory Journal|July 26, 2024
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studiesS Ashwin Reddy, Joseph Newman, Olivia C Leavy, et al.
The European Respiratory Journal|March 30, 2019
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysisEleni Sofianopoulou, Stephen Kaptoge, Stefan Gräf, et al.
Thorax|March 31, 2022
Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19Linzy Houchen-Wolloff, Krisnah Poinasamy, Kate Holmes, et al.
The European Respiratory Journal|July 8, 2020
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre studyRobert A Lewis, Iain Armstrong, Carmel Bergbaum, et al.
Pageof 4